Dose- and modality-specific effects of exercise on BDNF and depression in middle-aged and older adults with mild cognitive impairment: A Bayesian network meta-analysis

Gong Cheng, Jinhui Qiu, Shengtao Li · 2026

Read Dose- and modality-specific effects of exercise on BDNF and depression in middle-aged and older adults with mild cognitive impairment: A Bayesian network meta-analysis by Gong Cheng, Jinhui Qiu, Shengtao Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358178.txt.

Introduction

Gong Cheng, Jinhui Qiu, and Shengtao Li published this research article in PLOS ONE in 2026. It is a Bayesian network meta-analysis of exercise and the brain. The authors examine effects on BDNF, a protein that supports brain cells, and on depression, in adults in midlife and old age whose memory and thinking have mildly declined.

The analysis separates effects by dose and modality, meaning how much exercise and which kind, such as aerobic or resistance training. Combining many trials in a network lets the authors rank options never compared directly. Clinicians advising patients with early memory problems can use the ranking to suggest exercise types with the best support.

Catalog record

CREATORGong Cheng, Jinhui Qiu, Shengtao Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61710
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0358178

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Dose- and modality-specific effects of exercise on BDNF and depression in middle-aged and older adults with mild cognitive impairment: A Bayesian network meta-analysis

Gong Cheng, Jinhui Qiu, Shengtao Li

ABSTRACT
Objective: To evaluate the effects of exercise modality and weekly exercise dose on peripheral brain-derived neurotrophic factor (BDNF) and depressive symptoms in middle-aged and older adults with mild cognitive impairment (MCI), and to examine the robustness of the dose-specific predictions from the primary quadratic model across alternative dose–response functions. Methods: PubMed, Embase, Web of Science, the Cochrane Library, and APA PsycInfo were searched from inception to 13 April 2026. Randomized controlled trials involving adults aged 50 years or older with MCI and reporting BDNF or depression-related outcomes were included. Effect sizes were expressed as Hedges’ g. Separate Bayesian random-effects network dose–response meta-analyses were conducted for BDNF, overall depressive symptoms, and modality-specific depressive symptoms. The quadratic model was used as the primary model to predict intervention effects at different exercise doses. Linear, Emax, and natural cubic spline models were fitted as functional-form sensitivity analyses. Results: Twenty-eight studies involving 2,262 participants were included. In the primary quadratic analysis, the largest model-predicted effect on BDNF occurred at 440 MET-min/week (posterior mean, 0.752; 95% credible interval [CrI], 0.287 to 1.249), whereas the largest model-predicted effect on depressive symptoms occurred at 670 MET-min/week (posterior mean, 0.382; 95% CrI, 0.147 to 0.674). Dancing and multicomponent exercise showed comparatively favourable estimates at selected dose levels, whereas estimates for Tai Chi, walking, and yoga were less precise. Functional-form sensitivity analyses identified different dose locations for the maximum predicted effects. Therefore, 440 and 670 MET-min/week represent the maximum prediction points for BDNF and depressive symptoms, respectively, under the primary quadratic model, rather than established optimal exercise doses. Conclusion: Exercise interventions were associated with increased peripheral BDNF levels and improved depressive symptoms in middle-aged and older adults with MCI. The primary quadratic model predicted the largest effects at 440 MET-min/week for BDNF and 670 MET-min/week for depressive symptoms, suggesting a potentially non-linear dose–response relationship. Although these prediction points are important findings of the quadratic analysis, cross-model sensitivity indicates that they should be used to inform future dose-ranging research rather than be regarded as confirmed clinical optima.

Read the complete text